I Gaertner
Overview
Explore the profile of I Gaertner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
188
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bucheler R, Gleiter C, Schwoerer P, Gaertner I
Pharmacopsychiatry
. 2005 Feb;
38(1):1-5.
PMID: 15706458
Introduction: : We want to call attention to a mint plant, called diviner's sage ( Salvia divinorum), originally used in shamanic ceremonies of the Mazatec Indians of Mexico. On numerous...
2.
Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, et al.
Pharmacopsychiatry
. 2004 Nov;
37(6):243-65.
PMID: 15551191
Therapeutic Drug Monitoring (TDM) is a valid tool to optimise pharmacotherapy. It enables the clinician to adjust the dosage of drugs according to the characteristics of the individual patient. In...
3.
Baumann P, Hiemke C, Ulrich S, Gaertner I, Rao M, Eckermann G, et al.
Ther Drug Monit
. 2004 Jul;
26(2):167-70.
PMID: 15228159
TDM of psychotropic drugs is widely used, but there is little consensus regarding its optimal use in the clinical context. This prompted a multidisciplinary group comprised of clinical biochemists, clinical...
4.
Muller M, Dragicevic A, Fric M, Gaertner I, Grasmader K, Hartter S, et al.
Pharmacopsychiatry
. 2003 Jun;
36(3):98-104.
PMID: 12806567
Therapeutic drug monitoring (TDM) of tricyclic antidepressants (TCA) is established in the treatment of depression to optimize outcome and safety. However, there are few reports on TDM under naturalistic clinical...
5.
Koehnke M, Schick S, Lutz U, Willecke M, Koehnke A, Kolb W, et al.
J Neural Transm (Vienna)
. 2002 Nov;
109(11):1423-9.
PMID: 12454738
Neuropeptide Y (NPY) modulates ethanol drinking in rodents. The C-allele of the T1128C polymorphism of the human NPY gene has been previously associated with elevated alcohol consumption in a Finn...
6.
Kohnke M, Stosser D, Gaertner I, BARTH G
Pharmacopsychiatry
. 2002 Jul;
35(3):116-8.
PMID: 12107857
In contrast to several authors who found hepatic cytochrome P 450 2D6 (CYP2D6) metabolising status to be clinically unimportant in treatment with the CYP2D6 substrate, risperidone, we report on a...
7.
Eschweiler G, Bartels M, Langle G, Wild B, Gaertner I, Nickola M
Pharmacopsychiatry
. 2002 Jul;
35(3):96-100.
PMID: 12107853
Drug monitoring in psychiatry usually serves psychoactive drug plasma concentration measurement. Anticholinergic properties offer a faster approach to monitoring pharmacodynamic intraindividual effects of the drug by measuring their effects on...
8.
Gaertner I, Gilot C, Heidrich P
Pharmacopsychiatry
. 2002 Apr;
35(2):37-43.
PMID: 11951144
Objective And Method: The pharmacotherapy of 61 suicide victims (0.24 % of 27,078 admissions from January 1, 1980 to December 31, 1999) was compared to that of a control group...
9.
Gaertner I, Gaertner H, Vonthein R, Dietz K
J Clin Psychopharmacol
. 2001 Jun;
21(3):305-10.
PMID: 11386494
Twenty-three outpatients with schizophrenia (ICD-10 F20.xx) treated with clozapine (CZ) as monotherapy entered a prospective study on relapse prevention. Every 4 weeks, psychopathology was assessed by the Brief Psychiatric Rating...
10.
Schaber G, Wiatr G, WACHSMUTH H, Dachtler M, Albert K, Gaertner I, et al.
Drug Metab Dispos
. 2001 May;
29(6):923-31.
PMID: 11353764
Biotransformation products of the atypical neuroleptic clozapine were isolated from urine samples of three schizophrenic patients by solid-phase extraction, liquid-liquid extraction for the separation of unpolar and polar metabolites, and...